LONDON/ZURICH/LOS ANGELES (Reuters) – Nestle’s $7 billion licensing deal for Starbucks’ retail business gives it a much-needed boost in its battle against JAB, the privately owned investment firm stirring up the coffee industry with a string of deals. JAB, the family office of Europe’s billionaire Reimann clan, has built up the world’s second-largest coffee business over the past five years.
WASHINGTON (Reuters) – Boeing Co’s chief executive said on Wednesday the company will ensure its 737 production will not be hurt after the U.S. revoked its license to sell jets to Iran Air and that none of the 737 aircraft it had expected to sell to Iran were in the backlog of orders.
OMAHA, Neb. (Reuters) – Ketchup, bologna and Jell-O don’t excite Wall Street. But a big deal might whet its appetite for Kraft Heinz Co .
(Reuters) – Amazon.com struck a deal with Sears Holdings Corp to provide tire services, boosting traffic at the ailing department store and extending the online retailer’s growing stable of alliances with brick-and-mortar companies.
(Reuters) – U.S stocks advanced on Wednesday as a surge in oil prices boosted energy stocks following President Donald Trump’s decision to withdraw the United States from a nuclear deal with Iran.
Pharmaceutical giant Novartis is among the companies listed in paying Essential Consulting, a firm linked to Michael Cohen, President Donald Trump’s lawyer. Novartis signed a $100,000 a month contract with Cohen’s firm in February 2017. “Novartis determined that Michael Cohen and Essential Consultants would be unable to provide the services that Novartis had anticipated related to US healthcare policy matters,” the company said in a statement. …read more […]
AstraZeneca (NYSE: AZN) is a large cap company that operates within the pharmaceutical industry. Its market cap is $92 billion today and the total one-year return is 24.61% for shareholders.
AstraZeneca stock is beating the market, and it reports earnings soon. But does that make it a good buy today? To answer this question we’ve turned to the Investment U Stock Grader. Our research team built this system to diagnose the financial health of a company.
Our system looks at six key metrics…
[iu-adbox]
✗ Earnings-per-Share (EPS) Growth: AstraZeneca reported a recent EPS growth rate of -29.45%. That’s below the pharmaceutical industry average …read more […]
WASHINGTON (Reuters) – U.S. producer prices barely rose in April after strong gains in the first quarter, held back by a moderation in the cost of services such as hotel accommodation and healthcare, which could ease fears that inflation pressures were rapidly building up.
NEW YORK (Reuters) – Crude oil prices rose to 3-1/2-year highs on Wednesday following President Donald Trump’s decision to withdraw the United States from a nuclear deal with Iran, a move that helped lift equity markets as Exxon Mobil, Chevron and other oil majors rallied.
(Reuters) – Wall Street was higher on Wednesday, with energy shares getting a boost from a surge in oil prices after President Donald Trump pulled the United States out of a nuclear deal with Iran.
If you want proof that life isn’t always fair, look no further than Weibo Corp (ADR) (NASDAQ:WB) — one of the most popular social media sites in China. Weibo earnings were released Wednesday morning. The company managed to top its first-quarter sales and earnings estimates — quite firmly, in fact. …read more […]
DUBAI (Reuters) – Surging oil prices mean the big Arab countries of the Gulf — especially Saudi Arabia — look set to gain financially as well as politically from U.S. President Donald Trump’s decision to pull out of the Iran nuclear deal.
“Suppose you could make money trading harvested baby brains. Would you do it?” asked Charlie Munger, Berkshire Hathaway’s (NYSE: BRK) outspoken vice chairman. To him, bitcoin is just as bad.
Munger and Warren Buffett set the Twitterverse afire by poo-pooing bitcoin and cryptocurrency at Berkshire’s recent annual shareholder meeting.
But Munger did admit that blockchain, the computer science behind bitcoin, “is a great triumph of the human mind.”
I agree with him there.
But today I’m talking about perhaps the most controversial investment opportunity in history… an opportunity formed by the colliding worlds of cryptocurrencies and marijuana.
The two are made for each other.
And the …read more […]
Republican voters rejected ex-convict Don Blankenship in a West Virginia Senate primary in which he sold himself as “Trumpier than Trump” but was vigorously opposed by Trump himself. GOP voters in Indiana, meanwhile, chose wealthy businessman Mike Braun over two sitting congressmen to lead the party’s charge against a vulnerable Democratic senator in the fall. President Donald Trump and his allies cheered the West Virginia result, which helped avert a potential political disaster for a GOP already bracing for major losses in the November midterm elections. …read more […]
The company’s stock hasn’t been this cheap in years. Time to buy? …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
